학술논문
Direct antiviral therapy for treatment of hepatitis C: A real-world study from Brazil
Document Type
Article
Author
Lobato, Cirley Maria de Oliveira; Codes, Liana; Silva, Giovanni Faria; Souza, Aécio Flávio Meirelles; Coelho, Henrique Sérgio Moraes; Pedroso, Maria Lucia Alves; Parise, Edison Roberto; Lima, Leila Maria Soares Tojal de Barros; Borba, Luiz Augusto; Evangelista, Andreia Silva; Rezende, Rosamar Eulira Fontes; Cheinquer, Hugo; Kuniyoshi, Aline Satie Oba; Aires, Rodrigo Sebba; Quintela, Eloiza Helena Dias; Mendes, Liliana Sampaio Costa; Nascimento, Fábio Carneiro Vosqui; Medeiros Filho, José Eymard Moraes de; Ferraz, Maria Lúcia Cardoso Gomes; Abdala, Edson; Bittencourt, Paulo Lisboa; de Souza Paiva Ferreira, Adalgisa; Salcedo, Juan Miguel Villalobos; de Lucca Schiavon, Leonardo; de Almeida Lopes, Edmundo Pessoa; Pessôa, Mário Guimarães; Gonçalves, Luciana Lofêgo; Souto, Francisco José Dutra; Hyppolito, Elodie Bomfim; Pereira, Gustavo Henrique Santos; Mattos, Angelo A.; de Cássia Martins Alves Silva, Rita; de Lourdes Candolo Martinelli, Ana; Ivantes, Claudia Alexandra Pontes; Mello, Carlos Eduardo Brandão; Gomide, Geisa Perez Medina; Sette Junior, Hoel; de Tarso Aparecida Pinto, Paulo; Romeiro, Fernando Gomes; de Castro Lima, José Milton; Altikes, Isaac; Lyra, André Castro; Garcia, Raquel Francine Liermann; Villela-Nogueira, Cristiane Alves; Cuminale, Renata Cruvinel Cabral; de Omena, Andrea Magalhães Agra; Schiavon, Janaina Luz Narciso; Batista, Andrea Doria; de Liz Pellegrim Sanchez Lermen, Rafaela; Coral, Gabriela Perdomo; Paraná, Raymundo; Tovo, Cristiane Valle; Terrabuio, Débora Raquel Benedita; Filgueira, Norma Arteiro; de Paula Pessoa, Francisco Sergio Rangel; de Araújo, Fernando Antônio Barreiros; Strauss, Edna; Rocha, Cristina Melo; Ferreira, Paulo Roberto Abrão; Ruffeil, Nilma Lucia Sampaio
Source
Annals of Hepatology; November-December 2019, Vol. 18 Issue: 6 p849-854, 6p
Subject
Language
ISSN
16652681
Abstract
Direct antiviral agents (DAAs) including sofosbuvir (SOF), daclatasvir (DCV), simeprevir (SIM) and ombitasvir, paritaprevir and dasabuvir were introduced 2015 in Brazil for treatment of hepatitis C virus (HCV) infection. The aims of this study were to assess effectiveness and safety of HCV treatment with DAA in real-life world in a highly admixed population from Brazil.